Abstract
An increasing number of men diagnosed with localised prostate cancer has been accompanied by more men being considered for active surveillance as a management option. Here the author provides an update on recent developments in active surveillance and changes to NICE guidance.
Original language | English |
---|---|
Pages (from-to) | 8-11 |
Number of pages | 3 |
Journal | Trends in Urology & Men's Health |
Volume | 11 |
Issue number | 1 |
DOIs | |
Publication status | Published - 27 Jan 2020 |